SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The Fraud of Biological Psychiatry -- Ignore unavailable to you. Want to Upgrade?


To: Original Mad Dog who wrote (119)8/11/2000 12:19:48 PM
From: Smart_Asset  Read Replies (2) | Respond to of 444
 
If fat people die quicker and suffer more than optimal weight people, and suffer more diseases and maladies due to their weight, should someone not "medicalize" the issue of obesity?

Certainly "someone" should medicalize the issue of obesity. The medical profession should do that with the underlying premise that fat is unhealthy. What many object to is that the pharmaceutical industry medicalizes health issues with the underlying premise that dollars can be made from magic pills.

Note that the quote is from the pharmaceutical industry and not the medical profession per se.

``Part of our challenge moving forward with Xenical is to 'medicalize' weight management to physicians,'' Terence Hurley, a Roche spokesman, said.

Is that the tail wagging the original mad dog?



To: Original Mad Dog who wrote (119)8/11/2000 5:11:06 PM
From: Don Pueblo  Read Replies (1) | Respond to of 444
 
This guy on the street saw me wearing my SI t-shirt today and walked up to me and said:

"Hey! What's your alias on Silicon Investor? I go on that site every day. I'm a 'lurker'"

I said, "Uh...well, it's kinda secret. I don't really want anyone to know who I am. It's an art thing. I'm an artist."

He said, "Oh! That's good! OK, never mind."

He met Mr. Chicken, and lived to tell the tale! <G>



To: Original Mad Dog who wrote (119)8/12/2000 2:40:28 PM
From: Don Pueblo  Read Replies (1) | Respond to of 444
 
Pyschiatric Drug Initiative

Rise in Prescriptions for Kids Leads to Federal Effort


W A S H I N G T O N, March 20 — The White House planned to announce today a push to reverse a sharp rise in U.S. preschool children using Ritalin, Prozac and other psychiatric drugs, the New York Times reported.

Citing Clinton administration officials, the Times reported in Monday’s editions that the federal government planned to inform parents and teachers about the risks of using the drugs on preschoolers.

Among some of the campaign’s other initiatives, the Food and Drug Administration will develop new drug labels and the National Institutes of Health will begin a nationwide study of Ritalin use in children under the age of 6, the Times said.

According to the Times, first lady Hillary Rodham Clinton and federal health officials were set to meet today with parents, psychiatrists, pediatricians, psychologists and others.

Drugs Not First Option

The administration also planned to issue a statement declaring that “the use of medication is not generally the first option for a preschool child with a psychiatric disorder,” the Times said.

Administration officials told the Times that the effort was inspired mainly by Mrs. Clinton, now a candidate for the U.S. Senate in New York. The officials said Mrs. Clinton wanted to announce steps after seeing the immense public concern about the use of powerful pills to treat toddlers with emotional and behavioral disorders.

In a Journal of the American Medical Association study last month, researchers reported that there apparently had been an acute increase in the number of preschoolers taking psychotropic drugs, particularly stimulants such as Ritalin and antidepressants such as Prozac, the Times said.

Switzerland’s Novartis AG makes Ritalin. Eli Lilly and Co. makes Prozac.

abcnews.go.com